Table 2.
Comparative outcomes in serum enzymatic changes.
| Variable | HBOT (n=20) | Control (n=21) | P-value1 |
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| CPK(U/L) | |||
| T1 | 245.4 ± 109.8 | 342.1 ± 496.8 | 0.404 |
| (166–1167) | (82–289) | ||
| T3 | 158.5 ± 78.0 | 327.1 ± 181.1 | 0.001 |
| (62–275) | (152–796) | ||
| P-value2 | 0.005 | 0.908 | |
|
| |||
| GOT(U/L) | |||
| T1 | 21.8 ± 3.9 | 24.9 ± 8.8 | 0.402 |
| (18–45) | (11–30) | ||
| T3 | 18.2 ± 5.0 | 27.1 ± 12.6 | 0.004 |
| (13–32) | (12–38) | ||
| P-value2 | <0.001 | 0.483 | |
|
| |||
| Myoglobin (ng/mL) | |||
| T1 | 33.9 ± 15.4 | 35.6 ± 24.3 | 0.584 |
| (20.5–94.5) | (12.6–39.1) | ||
| T3 | 19.4 ± 10.2 | 43.3 ± 19.4 | <0.001 |
| (13–17.5) | (14.9–84.7) | ||
| P-value2 | 0.001 | 0.280 | |
|
| |||
| BUN (mg/dL) | |||
| T1 | 15.2 ± 2.7 | 14.2 ± 3.1 | 0.188 |
| (10–20) | (10–16) | ||
| T3 | 14.6 ± 3.3 | 14.5 ± 2.9 | 0.858 |
| (9–15) | (10–17) | ||
| P-value2 | 0.371 | 0.640 | |
|
| |||
| Lactate (mg/dL) | |||
| T1 | 11.0 ± 3.9 | 11.1 ± 4.3 | 0.958 |
| (5.1–20.8) | (5.4–19) | ||
| T3 | 11.2 ± 4.0 | 12.5 ± 3.7 | 0.163 |
| (6.5–18.6) | (8.3–36) | ||
| P-value2 | 0.893 | 0.123 | |
∗Mann-Whitney U test was used to compare 2 groups
∗ Generalized Estimating Equation (GEE) model was used to compare T1-T3
∗P-value1: Comparison of data between HBOT group and Control group
P-value2: Comparison of data between T1 and T3.
Note: The laboratory normal value of these blood markers: BUN: 6–21 mg/dl; CPK: 56–226 U/L; LT: 4.5–19.8 mg/dl; GOT: 0–37 U/L; MB: 17.4–105.7 ng/ml.